Clinical Trials Browser

Anus Neoplasms, Rectal Neoplasms, HIV Infections

Urinary Bladder Neoplasms

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Mediastinal Neoplasms, Pleural Neoplasms, Sarcoma

Anal Canal Carcinoma, Anus Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Appendiceal Neoplasms, Colorectal Neoplasms

Appendiceal Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Colorectal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Urinary Bladder Neoplasms

Carcinoma, Hepatocellular, Liver Neoplasms

Peritoneal Neoplasms, Stomach Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

Locally Advanced Anal Canal Cancer

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Adenocarcinoma, Stomach Neoplasms

Breast Neoplasms

Urothelial Carcinoma of the Bladder

Pancreatic Neoplasms

Carcinoma, Transitional Cell

Appendiceal Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Stomach Neoplasms, Colorectal Neoplasms

Urinary Bladder Neoplasms

Peritoneal Neoplasms

Anus Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Metastasis

Appendiceal Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

Neoplasm Metastasis, Colorectal Neoplasms

Gastrointestinal Neoplasms

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

Urinary Bladder Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Appendiceal Neoplasms

Anus Neoplasms

Esophageal Neoplasms, Stomach Neoplasms

Neoplasm Metastasis

Carcinoma, Hepatocellular

Lung Neoplasms, Pancoast Syndrome

Carcinoma, Hepatocellular

Biliary Tract Neoplasms

Colorectal Neoplasms

Carcinoma, Hepatocellular, Liver Neoplasms

Mesothelioma, Malignant

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Mesothelioma, Malignant

Pancreatic Neoplasms

Clinical Trials

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Phase II Trial of Lung Chemoemobolization

Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study

A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)

ICARuS

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Standard Therapies

A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial

A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma

Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

OHAI-NMIBC-01

CANAL-IMRT-01

IMGeS

GAIN INST

Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology

SAFIR02_Breast

Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)

Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer

Trial of Mitomycin C During Nephroureterectomy for Urothelial Carcinoma

HIPEC for Peritoneal Carcinomatosis

Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer

Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer

Proton Therapy in Reducing Toxicity in Anal Cancer

POLO

Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver

Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis

Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer

WUHIPEC02

Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric Cancer

Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorectal Cancer

CALIBER

Individualized Drug Treatment for Treating Patients With Pancreatic Cancer

Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 Gene

Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix

Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal Cancer

Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer

Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant Ascites

Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma

Trial of Pre-operative Chemoradiotherapy Followed by Surgical Resection in Pancoast Tumors (JCOG 9806)

The Efficacy of 5-fluorouracil/Mitomycin for the Patients With Pulmonary Metastasis of Hepatocellular Carcinoma

BIT-2

A Study of Mitomycin C, Irinotecan, and Cetuximab

Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery

Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer

Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma

Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus

Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus

S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer